You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

27 April 2018

Tenofovir is safe for pregnant women living with HIV and their babies

Reassurance for women living with HIV as commonly prescribed HIV drug deemed as safe as other regimes.

0
23 April 2018

First global comparison reveals stark health inequalities among adolescents born with HIV.

New research highlights significant gaps in health outcomes for adolescents born with HIV across the world – but paints a hopeful picture for the future as treatment access expands.

0
19 April 2018

Safe and effective $300 hepatitis C treatment a global game-changer

Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.

0
17 April 2018

The girl effect: how teenage boys are likely to listen to girls over VMMC

Adolescent girls have an important role to play in influencing adolescent boys’ decision to undergo voluntary medical male circumcision (VMMC), new research suggests.

0
12 April 2018

India could shift from efavirenz to dolutegravir for HIV treatment – at no extra cost, new research suggests

Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.

0
09 April 2018

HIV criminalisation deters men from testing and can increase HIV transmission rates

Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status.

0
05 April 2018

Violence a major driver for teens not taking their HIV treatment

Adolescent treatment non-adherence remains a major challenge in sub-Saharan Africa. Addressing structural barriers to care retention, such as violence, could be key.

0